Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 170Terminated 42Withdrawn 12Recruiting 8Active not recruiting 8Unknown 2Suspended 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 31Neoplasms 28Colorectal Neoplasms 20Prostatic Neoplasms 17Lung Neoplasms 14Leukemia, Myeloid, Acute 12Glioblastoma 12Stomach Neoplasms 10Pancreatic Neoplasms 10Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Melanoma 8Glioma 8Brain Neoplasms 8Rectal Neoplasms 7Carcinoma, Hepatocellular 7Ovarian Neoplasms 6Neoplasm Metastasis 6Hematologic Neoplasms 6Carcinoma, Renal Cell 6Uterine Cervical Neoplasms 5Polycystic Ovary Syndrome 5Myelodysplastic Syndromes 5Multiple Myeloma 5Esophageal Neoplasms 5Triple Negative Breast Neoplasms 4Lymphoma, B-Cell 4Lymphoma 4Depression 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × OTHER × Leukemia, Myeloid, Accelerated Phase × Clear all
NCT05322850 2026-04-13

Phase I/II Trial: Engineered Donor Graft (Orca Q) for Pediatric Hematopoietic Cell Transplant (HCT)

University of Florida

Phase 1/2 Suspended
40 enrolled
LymphoidOther hematologic neoplasm

Disease, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡